Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- SAIL -13.5%, DBI -10.8%, UNFI -9.2%, UEC -4.8%, LE -4.4%, MTN -4.2%, AVO -2.8%
Other news:
- IDYA -7.7% (prices $300 mln equity offering consisting of common stock and warrants)
- NOVT -5.1% (to acquire Riverpoint Medical for up to $1.45 bln; reaffirms outlook; announces $300 million private placement)
- ATHE -5.1% (achieves alignment with U.S. FDA on Pivotal Phase 3 Program for ATH434 in multiple system atrophy)
- PRGO -2.4% (CEO resigns; names interim CEO)
- SPRB -2% (long-term Tralesinidase Alfa Enzyme Replacement Therapy data in Sanfilippo Syndrome Type B)
- OCS -1.2% (announces first patient randomized in PREDICT-1 registrational trial of licaminlimab, advancing precision medicine in dry eye disease)
- HNI -1.1% (unit introduces Levra, a new standard in performance seating)
- WCC -0.9% (to acquire Newark Engineering Group)